Scarring is reduced when heart attack patients receive stem cells

09/11/2013 | TCTMD.com

Treatment with autologous cardiac progenitor cells was linked with reductions in scar tissue and improvements in viable myocardium after a heart attack, according to a study in the Journal of the American College of Cardiology. Improved systolic function and greater scar tissue improvements were seen in the treatment group compared with controls, according to the 25-patient study, which was conducted at two centers.

View Full Article in:

TCTMD.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director Medical Affairs
Edwards Lifesciences
Irvine, CA
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Medical Director - Physician
Willamette Valley Community Health
Salem, OR
Area Reimbursement Manager (CT, MA, MD, ME, NH, NJ, NY, PA, VT)
SI-BONE, INC
Multiple Locations, SL_Multiple Locations
Medical Director - Physician
Willamette Valley Community Health
Salem, OR